July 24, 2018 - Diagnostic and consumer healthcare remote monitoring technology company Biotricity Inc. has completed ...
The use of non-invasive fractional flow reserve CT (FFR-CT) was the hottest topic discussed at the Society of ...
Ed Nicol, M.D., FSCCT, MBA, head of cardiac CT, Royal Brompton Hospital, London, and chair of the Society of ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
July 20, 2018 — Boston Scientific Corp. today has signed an agreement to acquire Claret Medical Inc., which has ...
Kavitha Chinnaiyan, M.D., FACC, FSCCT, associate professor, Oakland University, William Beaumont School of Medicine ...
Here are the stories and other content in the July-August 2018 issue of Diagnostic and Interventional Cardiology (DAIC) ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Avinger Inc. announced in June that several physicians have successfully treated over 40 patients for peripheral artery disease (PAD) in the United States across 13 sites with the next-generation Pantheris image-guided atherectomy system. This positive initial case experience in the U.S. adds to the impressive clinical results achieved in the first 30 cases completed in Germany earlier this year and provides a strong foundation for expanded market launch into all U.S. accounts, according to the company.
July 18, 2018 — Abbott announced it received approval from the U.S. Food and Drug Administration (FDA) for a next ...
Suhny Abbara, M.D., FSCCT, chief of cardiothoracic imaging and chair of the CT operations committee, University of Texas ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
A discussion with Gianluca Pontone, M.D., Ph.D., FSCCT, director of cardiovascular MRI, Centro Cardiologico Manzino ...
Jonathon Leipsic, M.D., FSCCT, professor of radiology and cardiology at the University of British Columbia, Vancouver ...
An interview with Patrick Serruys, M.D., Ph.D., Imperial College London, principal investigator of the SYNTAX III Trial ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
A discussion with Todd Villines, M.D., FACC, FAHA, FSCCT, director of cardiovascular research and cardiac CT programs at ...
A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and explore an unappreciated way the disease puts people at risk of falls and hospitalization.
Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for a less-invasive implant approach of its HVAD System, a left ventricular assist device (LVAD) for patients with advanced heart failure. The HVAD System is the smallest commercially available LVAD according to Medtronic, and the only LVAD approved in the U.S. for implant via thoracotomy, a small lateral, surgical incision between the patient's ribs on the left side of the chest.